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A 58-year-old Caucasian man experienced leg swelling and
weight gain, lasting for 3 weeks. Proteinuria on urinalysis
prompted nephrology referral. He had an 18-year history of
hypertension and proteinuria, with a 24-h urine protein level
of 2.85 g noted 8 years ago. Medical history included hyper-
tension, obesity, hyperlipidemia, and myocardial infarction.
His medications included metoprolol, amlodipine, olmesar-
tan, hydrochlorothiazide, rosuvastatin, and aspirin. He
smoked one pack of cigarettes daily for more than 20 years.
Physical examination was notable for a weight of 102 kg,
body mass index of 36 kg/m2, blood pressure of 140/
60mmHg, and bilateral pedal edema.
Urinalysis showed 300mg/dl protein, no glucose, two red
blood cells per high-power field, one white blood cell per
high-power field, and 24-h urine protein level of 5 g. Serum
creatinine was 0.95mg/dl (79.56 mmol/l), blood urea nitrogen
31mg/dl (11mmol/l), fasting glucose 90mg/dl (4.5mmol/l),
albumin 3.4 g/dl (34 g/l), cholesterol 213mg/dl (5.5mmol/l),
triglycerides 155mg/dl (1.75mmol/l), hemoglobin A1C 5.8%
(39.9mmol/mol), antinuclear antibody and hepatitis profile
negative, and serum and urine protein electrophoresis, and
serum-free kappa and lambda light chains normal. A renal
ultrasound was normal. A kidney biopsy showed increased
mesangial matrix with vague nodularity, a sclerotic pattern
for IgM and C3 on immunofluorescence, and basement
membrane thickening (Figure 1).
What is the diagnosis?
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Figure 1 | Renal biopsy. (a) Light microscopy shows increased mesangial matrix with early nodule formation, capillary wall thickening,
and arteriolar hyalinosis (periodic acid–Schiff). (b) Electron microscopy shows lamina densa thickening (up to 1290 nm), irregular
subendothelial space widening, and focal foot process effacement (no amyloid-type fibrils noted).
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The Diagnosis | Idiopathic nodular glomerulosclerosis
(ING) (aka pseudodiabetic
glomerulopathy)
In 1989, Alpers and Biava first reported ‘nodular mesangial
sclerosis’ as a distinct diagnostic entity, and later in 1999
Herzenberg et al.1 coined the term ‘idiopathic nodular
glomerulosclerosis’. The major differential diagnosis is
between diabetic glomerulosclerosis and ING. Both are
characterized by glomerular basement membrane (GBM)
thickening and nodular/rounded expanded and lamellated
mesangial matrix (Kimmelstiel–Wilson nodules in diabetes).
Nodular diabetic glomerulosclerosis typically has more severe
GBM thickening and vascular disease than ING, and ING can
have more nodules per glomerulus than diabetes, and the
nodules are more likely to be isometric. However, these
morphological nuances cannot reliably distinguish between
ING and diabetes; rather, clinical correlation and a history of
diabetes make the diagnosis. Other conditions that can produce
mesangial nodules are more readily differentiated from ING,
using their chief distinguishing characteristics (Table 1).
Patients with ING are typically older white men with a
history of hyperlipidemia, long-standing hypertension, and
smoking, who present with renal insufficiency and nephrotic-
range proteinuria.2,3 Li et al.3 found a significantly higher
incidence of obesity (60%) and overweight (27%) in patients
diagnosed with ING. The pathogenesis of this process awaits
elucidation. Markowitz et al.2 hypothesized that ING results
from the interplay of hypertension and smoking in increasing
glomerular extracellular matrix production and angiogenesis.
Given the histological similarity to diabetes, it is tempting to
speculate that similar mechanisms, such as advanced glycation
end products and oxidative stress, are involved. The findings in
our patient of widening and rarefaction of the subendothelial
space, as well as hyalinosis of the efferent arteriole, suggest
chronic endothelial injury that may be pressure independent.3
Our patient was of course not diabetic and had a long
history of hyperlipidemia, hypertension, and smoking,
factors that are linked to this disease. His fasting plasma
glucose levels and hemoglobin A1C were normal, protein
electrophoresis and serum-free light chains did not show a
paraprotein, and ultrastructural examination of renal biopsy
did not reveal electron-dense deposits or amyloid-type fibrils.
Careful clinical evaluation and follow-up may be necessary to
fully exclude diabetes. Although data regarding prognosis are
limited, progression to end-stage renal disease has been
noted. Our management included aggressive control of blood
pressure, hyperlipidemia, and cessation of smoking.
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Table 1 |Differential diagnosis of nodular glomerulosclerosis
Entity Clinical LM IF EM
ING No history of DM Nodules may be more
frequent and isometric
than DM
Negative Fine fibrils in matrix,
but no deposits
Nodular diabetic glomerulosclerosis History of DM Scattered non-isometric
mesangial nodules
(1–2 per tuft)
Negative Fine fibrils in matrix,
but no deposits
Membranoproliferative glomerulo-
nephritis (primary or secondary)
Etiology dependent Double contours and
cellularity prominent
Positive for Ig
and/or C3
Granular deposits
Amyloidosis (AL or AA) Etiology dependent Congo red positive Monoclonal light
chain in AL
Random non-branching
fibrils (8–12nm)
Monoclonal Ig deposition disease Paraprotein in blood
and/or urine
Nodules more uniform than
DM and ING and show less
Jones positivity
Monoclonal light
and/or heavy chain
Finely granular deposits
Fibrillary glomerulonephritis Usually unexpected Congo red negative Polyclonal IgG and C3 Fibrils (16–24nm)
Immunotactoid glomerulonephritis Paraproteinemia or
lymphoproliferative
disorder
Congo red negative Monoclonal light
and/or heavy chain
Microtubules (20–50nm)
Fibronectin glomerulopathy Family history Mesangial deposits are PAS
positive but Jones negative
Usually negative except
for fibronectin
Massive electron-dense deposits
(mostly amorphous) replacing
mesangial matrix; GBM of
normal thickness
Type III collagen glomerulopathy Blood and urine N-terminal
procollagen type III
peptide
May be hypercellular Negative Fibers with characteristic
60nm periodicity
Abbreviations: AA, amyloid associated; AL, amyloid light chain; DM, diabetes mellitus; EM, electron microscopy; GBM, glomerular basement membrane;
IF, immunofluorescence; Ig, immunoglobulin; ING, idiopathic nodular glomerulosclerosis; LM, light microscopy; PAS, periodic acid–Schiff.
make your d iagnos i s KM Baradhi et al.: Nodular glomerular sclerosis in a nondiabetic smoker
1142 Kidney International (2012) 82, 1141–1142
